Press Releases

DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
DiaMedica Announces Closing of $23 Million Public Offering of Common Shares
DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
DiaMedica Announces Proposed Public Offering of Common Shares
DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
RSS
Show All